Navigation Links
Intarcia Therapeutics Appoints Gino Santini To Its Board Of Directors
Date:7/26/2013

BOSTON, July 26, 2013 /PRNewswire/ -- Intarcia Therapeutics, Inc. today announced the appointment of Gino Santini to its Board of Directors. Mr. Santini is a former top executive with Eli Lilly and Company, and is globally respected in the industry after nearly three decades of global pharmaceutical experience. Mr. Santini now will help guide Intarcia through the final stages of development, partnering, and early commercialization of its lead therapeutic candidate, ITCA 650 (a breakthrough once- or twice-yearly GLP-1 for type 2 diabetes that is currently in Phase 3 clinical trials). Mr. Santini will also have significant input on the continuing efforts to build out the Company's product pipeline.

"As we look to continue to strengthen our Board, Gino stood out as an exceptional candidate and proven leader in the industry whose qualifications are well suited to help us meet all our opportunities to advance our Company," said Kurt Graves, Chairman, President and CEO of Intarcia. "We are delighted to welcome Gino to the Intarcia Board of Directors, and we look forward to gaining the benefit of his extensive global operating experience, all of his business development acumen, and his in-depth knowledge and insights in the diabetes marketplace."

Gino Santini began his distinguished career at Lilly as a Financial Planning Associate in Italy in 1983 and subsequently served in roles of increasing responsibility, including: Pharmaceutical Director in Belgium, General Manager in Mexico City, Area Director of Latin America, President of Lilly's women's health business, and President of U.S. Operations. In his final role as Senior Vice President of Corporate Strategy and Business Development and a member o
'/>"/>

SOURCE Intarcia Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Intarcia Appoints Owen Hughes Chief Business Officer and Head of Corporate Development
2. Intarcia Enrolls First Patients in "FREEDOM" Global Phase 3 Program for ITCA 650 in Type 2 Diabetes
3. Intarcia Supports American Diabetes Association Call For Independent Review Of Incretin-Based Therapies
4. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
5. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
6. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
7. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
8. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
9. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
10. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
11. Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2014)... and HERZLIYA PITUACH, Israel , ... (NASDAQ: IMNP ) announced today that its Board ... Board succeeding Dr. Daniel Teper who continues as ... member of Immune,s Board of Directors since 2013. ... am delighted to represent the interest of shareholders and to ...
(Date:12/15/2014)... N.Y. , Dec. 15, 2014 As ... SPL (Structured Product Labeling) markup language standard, content teams ... understanding and skills to work with the standard. Starting ... series of three webinars on the benefits and the ... one-hour webinars will be facilitated by Howard Shatz ...
(Date:12/14/2014)... 2014  ChartSpan, a consumer platform for patients managing ... iPad medical app in the United States ... ChartSpan is an iPhone and iPad ... and send electronic healthcare records. The product was built ... of waiting for the healthcare system to deliver on ...
Breaking Medicine Technology:Immune Pharmaceuticals Elects Daniel Kazado as New Chairman of the Board. 2Immune Pharmaceuticals Elects Daniel Kazado as New Chairman of the Board. 3Immune Pharmaceuticals Elects Daniel Kazado as New Chairman of the Board. 4Data Conversion Laboratory Helping Life Sciences Content Producers Understand the Impact and Benefits of Structured Product Labeling 2Data Conversion Laboratory Helping Life Sciences Content Producers Understand the Impact and Benefits of Structured Product Labeling 3ChartSpan Becomes The Most Downloaded Medical App in America 2ChartSpan Becomes The Most Downloaded Medical App in America 3
... ST. LOUIS, March 14, 2011 Members served by Express ... pharmacy benefits account on their smart phones using a new ... Members can download the Express Rx app from ... including those on BlackBerry devices, can access the mobile-optimized website ...
... Streamline Health Solutions, Inc. (Nasdaq: STRM ... for hospitals, announced today that Rick Leach has been ... March 14, 2011. With more than 20 years of ... an extensive background in developing and marketing healthcare information ...
Cached Medicine Technology:New Application Offers Express Scripts Members Convenient Account Access Across a Broad Range of Mobile Phone Platforms 2Streamline Health Appoints Rick Leach as Senior Vice President and Chief Marketing Officer 2Streamline Health Appoints Rick Leach as Senior Vice President and Chief Marketing Officer 3Streamline Health Appoints Rick Leach as Senior Vice President and Chief Marketing Officer 4
(Date:12/17/2014)... In its comprehensive analysis of medical ... Claim Review division have recently identified out-of-network and medical ... savings are achieved on behalf of employer-clients. , ... in savings to Argus each year, with a total ... by Tom Doney, Cypress president and CEO, these in-depth ...
(Date:12/17/2014)... Mamaroneck, NY (PRWEB) December 17, 2014 ... man who recently brought videos of MIT economist and ... and best-selling author James O’Keefe conducted the interview, which ... “Rich” stated that there was intentional mislabeling in the ... agenda in the bill: A two-hundred-and-fifty billion dollar per ...
(Date:12/17/2014)... Dec. 16, 2014 (HealthDay News) -- Expectant parents should ... and Drug Administration recommends. Use of ultrasound imaging ... is not entirely risk-free, the agency warns. ... harm due to ultrasound imaging and heartbeat monitors, prudent ... is important," Shahram Vaezy, an FDA biomedical engineer, said ...
(Date:12/17/2014)... HealthDay Reporter TUESDAY, Dec. 16, ... approaching, a new study reveals that states that routinely perform ... drivers on their roads. The finding suggests that states ... to deter inebriated revelers from getting behind the wheel in ... passed regarding drinking and driving," said study lead author James ...
(Date:12/15/2014)... OR (PRWEB) December 15, 2014 A ... by United States women as impacting skin health and ... “Four C’s of skin care.” Water and health advocate ... in a recent article describing the survey and the ... every item in every category discussed would benefit from ...
Breaking Medicine News(10 mins):Health News:Out-of-Network & Medical Necessity Reviews among Top Ways TPA Identifies Significant Medical Claim Savings 2Health News:Project Veritas: James O’Keefe Interviews the Man Who Discovered Jonathan Gruber Videos 2Health News:FDA Warns Against Fetal 'Keepsake' Videos 2Health News:Enforcement of Drunk Driving Laws Makes Roads Safer, Study Finds 2Health News:Enforcement of Drunk Driving Laws Makes Roads Safer, Study Finds 3Health News:Water and health advocate Sharon Kleyne adds a “W” for fresh water to “four C’s of skin care” 2Health News:Water and health advocate Sharon Kleyne adds a “W” for fresh water to “four C’s of skin care” 3
... incidence of Alzheimer's disease nationwide, both the New York ... passed a resolution aimed at raising awareness of the ... this brain disorder. ,The resolution declared November ... 2007 as Memory Screening Day in New York State. ...
... export of herbal products and medicines has the potential to ... with the creation of exclusive export promotion zones (EPZ) ... exports can be accelerated with the setting up of EPZs ... a rate of over 25 percent in countries like the ...
... at the 61st Annual Meeting of the Society ... Corporation, announced the worldwide launch of the Cordis ... in angioplasty procedures for patients with carotid and ... unique high-pressure expansion and low profile .014 inch ...
... among asylum seekers in Denmark has proportionally tripled since 2001 ... a study published Thursday . ,Sixty-seven asylum seekers ... percent of the total -- tried to end their lives ... to Help Refugees said. ,That contrasted with the ...
... Titan, a TATA company, is in negotiations with Prof Vijay ... to the University of Arkansas, to start production of ... deal is yet to be finalized. ,Varadan holds ... and Neuro- Electronics, Sensors and Systems; High Density Electronics Center ...
... Project (MVP) today released new data on the performance ... suggesting that the new vaccine-- expected to sell initially ... effective in protecting African children and their communities than ... ,MVP, a partnership between the World Health ...
Cached Medicine News:Health News:New York Legislature Highlights for Awareness of Alzheimer's Disease 2Health News:New York Legislature Highlights for Awareness of Alzheimer's Disease 3Health News:Export of Herbal Products to Reach Rs.120 Billion by 2012: Study 2Health News:New Balloon Catheter Available Worldwide for Carotid and Renal Angioplasty 2Health News:Titan may Produce Glucose Watches Soon 2Health News:Improved Meningitis Vaccine for Africa Expected to End Deadly Scourge 2Health News:Improved Meningitis Vaccine for Africa Expected to End Deadly Scourge 3
... Forms strong flexible gels for ... clarifier: mixture of wide range ... water 10 mg/mL, clear, faintly ... molecular biology MP: 90 °C ...
Inquire...
Inquire...
... Melt), A low temperature agarose for ... , Optimal for in-gel restriction digestion/ligation and ... very manageable clear gel that provides excellent ... approximately 65°C and remains fluid at 37°C ...
Medicine Products: